Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Universal Subunit Vaccine (flu prevention)
- Development stage
- Preclinical
- Lead developer
- Engen Bio
- Modality
- Peptides, Vaccines & Immunotherapeutics
01
Overview
The Universal Subunit Vaccine (flu prevention) is a preclinical peptide-based subunit vaccine being developed by EnGen Bio for the prevention of Type A influenza. The vaccine is designed to target the highly conserved M1 matrix protein (specifically the M1 epitope) of the influenza A virus. Unlike traditional seasonal vaccines that target the rapidly mutating surface proteins hemagglutinin and neuraminidase, this candidate focuses on a conserved internal protein to provide broad, "universal" protection against diverse influenza A strains, including seasonal and pandemic variants. The development program encompasses both human and veterinary applications.
- Other names
- enGen-M1 matrix protein vaccineenGen-M-1 matrix protein vaccineenGen-M 1 matrix protein vaccineM1 epitope subunit vaccineM-1 epitope subunit vaccineM 1 epitope subunit vaccineUniversal Subunit Vaccine
02
Targets
M1 (Muscarinic acetylcholine receptor M1)
Beyond the preview
Go deeper on Universal Subunit Vaccine (flu prevention).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Universal Subunit Vaccine (flu prevention).